The results presented lower expressions of PTEN and PLZF in high-grade prostate cancer specimens (GS = 8,9) than in mediate-grade (GS = 7) and well-differentiated (GS = 5,6) specimens. This evidence concerns the gene ZBTB16 and Familial prostate cancer.